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Abstract 
Liquisolid technique is a novel process in which a liquid can be converted into a material that flows freely, is 
readily compressible. The carrier material in liquisolid compact comprises the liquid part, which is the liquid drug or a 
drug solution in liquid vehicles that are non-volatile. Solubility is the main parameter in the circulation of blood to achieve 
the whole concentration of the drug for pharmacological action. The rate of dissolution of drugs enhances in liquisolid 
technology. This in turn increases absorption and bioavailability subsequently. This review discusses the different 
advances and changes to improve liquisolid technology formulations and enhancement of dissolution rate of poorly soluble 
drugs. Most of the new chemical entities have high lipophilicity and poor water solubility, resulting in poor bioavailability. 
The release rate of these drugs should be increased in order to improve bioavailability. The technique is based on 
dissolving the insoluble drug in the solution loaded with non-volatile solvent. Then the dissolution rate of drug which is 
poorly soluble will rise. The enhanced bioavailability is due to the increased surface area of drug for release, increased 
drug aqueous solubility or improved wetting capacity. 
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1. Introduction  
The Liquisolid technique is a method that 
improves the dissolution rate of water-insoluble drugs and 
can alter it. The drugs that are unsolvable or poorly soluble 
are dissolved or dispersed in a significant non-volatile 
solvent in the liquisolid technique and changed by the use 
of carrier substance into free flow powder. Dissolution is a 
significant issue in absorption of the drug, chiefly in the 
drugs which are insoluble in water or poorly soluble, the 
liquisolid technology can improve it. A drug's therapeutic 
efficacy depends on the bioavailability that depends on drug 
solubility of molecules. Solubility is the main factor for 
achieving the preferred pharmacological response 
concentration of the drug in circulation of blood in the 
body.[1] Many approaches to formulation have been 
developed to enhance the solubility of drugs that are very 
less soluble in water. Micronization technique is the 
normally used approach that helps to get better drug 
solubility due to area of surface expansion, but the 
agglomeration style of micronized hydrophobic drugs 
makes it not as much effectual to keep away from the 
difficulty of solubility, especially while the drug is 
formulated in tablets or in encapsulations. In recent years, 
the term solid dispersion has grown an active curiosity in 
research to get better the dissolution of drug. The liquisolid 
technique, a novel advanced system, and a method for 
increasing dissolution, may conquer most of the barriers. 
First introduced by Spireas et al., this technique was used to 
fit in water-insoluble drugs into forms of fast release of 
solid dosage. The liquisolid systems intend principle is to 
hold powdered liquid drugs (i.e. drug solutions and liquid 
drugs). Liquisolid systems are considered free-flowing  
powders which we can compressed into tablets or can filled 
into capsules and containing a liquid non-volatile medium 
and particles of solid drugs.[2] The liquid medium can 
dissolve the solid drug particles or partially dissolve them 
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i.e. drug suspended into the organic solvents. With the 
mixing of appropriate excipients such as carrier and coating 
materials, the liquid medium can be transformed into a dry-
looking free-flowing powder which we can compressed. 
Liquisolid formulations, such as propylene glycol and 
polyethylene glycol, are used as liquid vehicles as orally 
preferable and are water-miscible organic solvents with 
increased boiling point. It is possible to espouse the various 
different grades of cellulose and lactose as carriers. On the 
other hand, as coating materials, simply excipients with 
very well particle size and greatly adsorptive properties, for 
instance silica powder can be used.[3] 
 
2. Previous advancement  
Liquisolid technology is used in the powdered 
solutions, a method which is depend on the reformation of a 
drug solution into a dry powder in a solvent which is non - 
volatile, with heavy particular surfaces primarily by liquid 
adsorbing. Though, for their dissolution forms, these types 
of manufacturing were examined even as in a form of 
powder dispersion, and in the form of tablets they cannot be 
compressed. Compression enhancers and the binders such 
as methyl cellulose, starch and polyethylene glycol have 
been included into these types of systems in next 
advancement on powdered solutions to get the better blend 
compatibilities.[4] Though, the product's stream and 
compression estate have never been justified and improved 
to the particular industrial and necessities in the 
examinations. Particularly, as in the form of tablets such 
customized powdered solutions were dense, considerable 
liquid-squeezed and inappropriately difficulty found with 
soft tablets. This slowed down the industrial function of 
these types of method. On the divergent, liquisolid 
compacts express adequate stream and compressibility. In 
the liquid medicine, we can simply use the drug solutions 
but also we can use the various emulsions and the 
suspensions. Thus, unlike powdered solutions, the liquisolid 
technology includes powdered drug solutions, suspensions, 
emulsions and powdered liquid drugs. 
 
3. Process and theory involved in liquisolid 
system 
The liquid medium is integrated into a carrier 
material when the drug is dissolved in that medium and this 
has in its interior surface and strictly matted fibers such as 
celluloses, and there is both absorption and adsorption. Its 
internal structure captures the liquid initially absorbed 
within the particles. After this method has been saturated, 
the liquid is absorbed onto the porous carrier particles inner 
and outer surfaces. Then the fabric material with elevated 
adsorption properties and big particular surface region 
offers the liquisolid structure with fluid features. 
In liquid vehicle solution the drug is present in 
the liquisolid systems while it is concurrently transported 
by powder. One of the anticipated mechanisms for 
explaining the improved dissolution rate from the liquisolid 
compacts is the wet capacity of the compacts in the 
dissolution media.[5] 
Non-volatile solvents can easily moisten drug 
molecules in the liquisolid compact by lowering the 
interface friction between the medium of solvent and the 
surface of the tablet. Liquisolid compacts can therefore be 
estimated to reveal enhanced release profiles of water-
insoluble drugs due to considerable increase in wet capacity 
and effective surface area for dissolution. The dissolution of 
drugs which are non polar is the rate at which 
gastrointestinal absorption partial, an enhanced 
bioavailability of the orally taken is achieved if a drug 
which is insoluble is in the solution and therefore the rate of 
dissolution is enhanced.[9] 
 
Fig. 1: Liquisolid System 
 
3.1 Liquisolid Formulations as a tool to enhance drug 
release 
 Many poorly soluble drugs were formulated as 
liquisolid systems and showed enhanced release of drugs. 
These drug delivery systems were formulated using various 
liquid vehicles, carrier and coating materials.[12] 
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Table 1.  Drugs with different liquid vehicles, carrier and coating materials for liquisolid technology 
Drug Liquid vehicle Carrier And Coating material 
Aceclofenac PEG MCC and HPMC 
Bromhexine HCL  MCC and Colloidal silica 
Carbamazepines PEG 200 MCC and Colloidal silica 
Clofibrate (liquid)  MCC and Colloidal silica 
Famotidine PG MCC and Colloidal silica 
Fenofibrate PEG 400 MCC and Colloidal silica 
Fenofibrate PG MCC and Colloidal silica 
Furosemide Synperonic PE/L MCC and Colloidal silica 
Glibenclamide PEG 400 MCC and Colloidal silica 
Griseofulvins PEG 400 MCC and Colloidal silica 
Hydrochlorothiazide PEG 200 MCC+Magnesium carbonate and colloidal silica 
Hydrocortosone PG MCC and Colloidal silica 
Hydrocortisone PEG 400 Various silica 
Ibuprofens PEG 300 MCC and Colloidal silica 
Indomethacin PG MCC and Colloidal silica 
Indomethacins PEG 400 MCC and HPMC 
Lamotrigin PEG 400 MCC and Colloidal silica 
Methyclothiazide PEG 400 MCC and Colloidal silica 
Naproxen Cremophore EL MCC and Colloidal silica 
Piroxicam Polysorbate 80 MCC and Colloidal silica 
Piroxicam PG MCC and Colloidal silica 
Polythiazide PEG 400 MCC and Colloidal silica 
Prednisolone PEG 400 Various silica 
Prednisolone PG MCC and Colloidal silica 
Prednisone PG MCC and Colloidal silica 
Prednisone PEG 400 Various Silica 
Repaglinide Polysorbate 80 MCC and Colloidal silica 
 
4. Main components of liquisolid system 
4.1 Coating Material and Carrier Material:  
Coating material forms a uniform film around 
carrier particles. This prevents particle aggregation and 
reduces inter-particulate friction. This phenomenon 
improves flowability and gives a dry-looking appearance to 
the liquisolid by covering the wet carrier particles and 
absorbing any excess liquid. Usually the coating materials 
are very fine. Example of coating material is colloidal silica 
of different grades similar to Aerosil 200. And the carrier 
material should have porous surface and closely matted 
fibers in its inertial. Carriers are involved in the liquid 
medication sorption process that improves the effective 
dissolution surface area. These help the compression as 
well. Carriers have a sufficient adsorption property due to 
relatively large, preferably porous particles and matted 
fibers contribute to the interior. E.g. Lactose and cellulose.  
4.2 Non-Volatile Solvent:  
The selected solvent should have the capability to 
dissolve the drug adequately. Appropriate vehicles are inert; 
firstly they are miscible with water and having increased 
boiling point, like propylene glycol and fixed oils. 
4.3 Disintegrant:  
The formulation kind and concentration will be 
based mostly on the observation's purpose while the use of 
disintegrant. Merging of super-disintegrant is positive for 
studies to improve solubility. Sodium starch glycolate is the 
most commonly used disintegrant.  
 
5. Mechanisms of increased drug release 
The three main mechanisms proposed include 
increased surface area of drug available for release, 
increased drug aqueous solubility due to the presence of 
non - volatile vehicle and improved drug particle wettability 
due to the cosolvent effect of the used vehicle.[6] 
5.1 Enhanced effectual Surface Area: 
In the liquid medium whenever the drug be 
dissolved within the liquisolid system and it is in a 
molecularly dispersed condition. Consequently, the drug’s 
surface area accessible for release in directly compressed 
tablets is more than that of moleculess of the drug. 
Consequently, by improving the solubility of the 
drug content and thus increasing the portion of the drug that 
is not dissolved in the liquid vehicle, the release rate 
decreases., the discharge rates in the liquid formulation may 
be exposed with many of drugs and to be directly 
proportional to the portion of the molecularly isolated drug 
(FM).[13] 
According to spireas FM as the fraction between 
the drug solubility, (Sd) the real concentration of the drug, 
(Cd) medium carried by all system. 
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Therefor, 
FM = Sd/Cd 
Where, FM is 1 
 
Furthermore, it is assumed that the adsorption and 
absorption of molecularly dispersed drugs on the surface 
and inside of the carrier molecule exerts an inhanced 
effective surface area usually available for mass movement 
during the method of drug dissolution. 
 
5.2 Enhanced Aqueous Solubility: 
For enhancing drug unharness to the primary 
methodology, the liquisolid systems are doubtless to boost 
the drug’s solubility. In fact, in a very liquisolid compact, 
the comparatively bit of liquid vehicle isn't adequate to 
extend the drug's overall solubility within the liquid 
medium. Though, within the the small - setting of the solid / 
liquid interface between a personal primary liquid particle 
and therefore the unharness medium, the quantity of liquid 
vehicle that spreads from one liquid particle along with the 
drug molecules could also be adequate to extend the drug's 
liquid solubility if the liquid vehicle will act as a cosolvent. 
In varied studies, the common raise in drug solubility and 
caused by liquisolid systems was established.[7] 
 
5.3 Better Wetting Properties: 
Because the liquid medium may also perform as a 
surface active agent or enclose stumpy tension on the 
surface, it boosts the various wetting properties of the 
molecules of main liquisolid. Contact angles
215
 and water-
rising times can demonstrate the wettability of these 
systems. The drug's adsorption on the carrier particles also 
increases the effective surface area, enhancing drug contact. 
 
6. Optimization of liquisolid formulation for 
enhanced drug release 
Optimizing the liquisolid method is mostly 
intended on improving the dissolution rate of drug 
formulation and flow properties. Since the releasing rates in 
formulation of liquid are directly proportional to the part of 
drug dispersed molecules (FM), elevated drug dose needs 
more liquid entities for the preferred discharge profile. In 
addition, high levels of carrier and coating materials are 
required to get liquisolid systems with acceptable 
flowability and compactability. This leads to an increase in 
tablet weight, however, ultimately difficulty in processing 
and swallowing manufacturing. Therefore, several 
formulation parameters need to be optimized to overcome 
these and various other liquisolid technology issues. These 
factors are shown in the table 2. 
Table 2. Formulation parameters for liquisolid system with rapid drug release 
Formulation parameters Optimization Effects 
Liquid Vehicle High solubility of drug in the vehicle  Increased fraction of the molecularly dispersed drug (FM)  
Carrier and coating  
Materials  
High specific area of surface  Increased liquid load factor (Lf)  
Addition of excipients  
 
Polyvinyl pyrrolidone  
(PVP)  
Increased liquid load factor (Lf)  
Increased viscosity of liquid vehicle  
Inhibition of precipitation  
Excipient ratio (R)  
 
High R-value  
 
Fast disintegration  
Inhibition of precipitation  
 
7. Alternative technologies 
The techniques that compete with the liquisolid 
technique are as shown in Table 3. Different solubilizers or 
hydrophilic polymers are used in solid dispersion 
technology. Different methods such as melting, solvent 
evaporation, condensation or cooling can be used to prepare 
solid dispersions; but the problem in this type of system 
involves the use of volatile solvents. Jain et al [8] studied 
the effect of powder processing performance on Fenofibrate 
formulations dissolution rate. It was discovered that milling 
a fenofibrate / excipient mixture was useful over milling the 
raw drug alone. In process C, a fast rate of release was 
studied. This method, however, involves using jet milling to 
reduce the active constituent's size. Complexation with 
cyclodextrins as a carrier seems to be a very effective 
process of inclusion. In terms of scale-up aspects, the 
process, involving simple stirring for a few hours and then 
filtering the complex, which is further dried, is very useful. 
However, this method's effectiveness is limited due to the 
cost of cylodextrins. Huang et al [10]. They used an 
emulsion solidification process to prepare ultrafine 
fenofibrate powder. The emulsion solidification process 
consisting of emulsifier, water and molten drug as oil phase 
was used without the use of any organic solvent. The 
effects on particle size and morphology of stirring velocity 
and volume ratios of hot emulsion to cold water as well as 
the impacts of various emulsifiers on emulsion were 
discussed. The property of dissolution was found to be 
improved enough than bulk fenofibrate. Although this 
process appears to be simple, during emulsification it 
requires high expertise and higher costs of emulsifier as 
well. Vogt et al [11] used technologies such as 
micronization with jet milling and then media milling with 
ball milling to obtain nanosized particles. Thereafter, spray 
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drying was also performed. Their limitations include high - 
end friction and spray drying technologies. Using an 
evaporative precipitation technique appears to give much 
smaller particle size down to nanometers, but this involves 
using an HPLC pump, heat exchanger, and a specially 
manufactured nozzle. Considering the limitations of the 
above technologies, liquisolid formulations can be said to 
be less expensive, easy to formulate, and high-performance 
dissolution and bioavailability systems. The above 
liquisolid technique advantages are based on available 
literature data and subject to case differences.[15] 
 
Table 3. Competing technologies with liquisolid technique 
Sr. No. Technique Mechanism 
1 Solid dispersion Hydrophilic polymers 
2 Processing with excipients 
using mills 
Processing of the bead mill and subsequent spraying 
3 Inclusion complexation Inclusion of active into clycodextrin structure 
4 Ultrafine active development Solidification process from emulsion 
5 Micronization Particle size reduction increasing surface area 
6 Nanosizing Bead mill processing and subsequent spray drying 
7 Evaporative precipitation 
into aqueous solution 
Precipitation of the drug in an aqueous surfactant solution dissolved in volatile solvent 
 
8. Conclusion 
Low water solubility is an inertial prolem with 
newly developed drugs changing to higher lipophilicities. 
The whole bioavailability for such drugs is frequently not 
achieved by standard formulation strategies. By increasing 
the release of drug, liquisolid technology has proven to be a 
beneficial innovative tool to improve bioavailability. It is an 
efficient technology in terms of manufacturing capacity and 
formulation’s low cost. This technology therefore has the 
potential for manufacturing on a large scale.  
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